Literature DB >> 2133253

Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome.

S Storti1, L Pagano, R Marra, A Grilli, G Falappa, A M De Gaetano, A M Ferrante, B Bizzi.   

Abstract

A patient with an inferior vena cava thrombosis in nephrotic syndrome was treated with heparin, AT-III concentrates and urokinase. After a few days on treatment he showed a complete resolution of the thrombosis. We suggest that this therapeutic combination may be a good approach to the treatment of thrombosis in nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2133253

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Pulse-spray thrombolysis of inferior vena cava thrombosis complicating filter placement.

Authors:  M E Hansen; G L Miller; K C Starks
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

2.  Antithrombin concentrate use in children: a multicenter cohort study.

Authors:  Trisha E Wong; Yuan-Shung Huang; Jason Weiser; Thomas V Brogan; Samir S Shah; Char M Witmer
Journal:  J Pediatr       Date:  2013-08-06       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.